CP
Clayton Partners’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-58,585
| Closed | -$1.69M | – | 40 |
|
|
2023
Q4 | $1.69M | Sell |
58,585
-8,108
| -12% | -$233K | 1.37% | 26 |
|
|
2023
Q3 | $2.21M | Buy |
66,693
+515
| +0.8% | +$17.1K | 1.88% | 21 |
|
|
2023
Q2 | $2.43M | Sell |
66,178
-421
| -0.6% | -$15.4K | 2.1% | 21 |
|
|
2023
Q1 | $2.72M | Sell |
66,599
-9,862
| -13% | -$402K | 2.65% | 16 |
|
|
2022
Q4 | $3.92M | Buy |
76,461
+10,232
| +15% | +$524K | 3.71% | 9 |
|
|
2022
Q3 | $2.9M | Buy |
66,229
+265
| +0.4% | +$11.6K | 3.27% | 11 |
|
|
2022
Q2 | $3.46M | Sell |
65,964
-229
| -0.3% | -$12K | 3.73% | 11 |
|
|
2022
Q1 | $3.43M | Buy |
66,193
+192
| +0.3% | +$9.94K | 2.89% | 13 |
|
|
2021
Q4 | $3.9M | Buy |
66,001
+4,973
| +8% | +$294K | 3.4% | 9 |
|
|
2021
Q3 | $2.63M | Buy |
61,028
+62
| +0.1% | +$2.67K | 2.51% | 19 |
|
|
2021
Q2 | $2.39M | Buy |
60,966
+2,566
| +4% | +$100K | 2.01% | 22 |
|
|
2021
Q1 | $2.12M | Buy |
+58,400
| New | +$2.12M | 2.04% | 21 |
|